Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Open House Medicinal Department Treaties Tofacitinib, Atc L04af01 2025-12-13
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Nilotinib (except As A Dispatch In Apple Sauce) F. D. Z. 01.8.25 - 31.7.27 (plus Extension Option 1x12 Month) 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Fluorouracil, Atc D11af05 For The Time 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-13
Germany Open House Pharmaceutical Dact Treaties Formoterol, Glycopyrronium Bromide And Beclometason, Atc R03al09 2025-12-13
Germany Open House Medicinal Department Of Pegintereron Beta-1a, Atc L03ab13 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Safinamide, Atc N04bd03 For The Period 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-13
Germany Completion Of A Non -exclusive Discount Agreement According To Section 130a (8) Sgb V On The Active Ingredient Colchicin, Atc M04ac01 For The Time 01.08.2025 - 31.07.2027 (plus Extension Option 1x12 Months) 2025-12-13
Germany Open House Pharmaceuticals Budesonide, Atc A07ea06 2025-12-13
Bulgaria Delivery Of Medical Supplies 2025-12-13
Germany Completion Non -existing Discount Agreements According To § 130a Para. 8 Sgb V To The Active Ingredients Mentioned With A Final Option In The Context Of The So -called Open -house Process. 2025-12-13
Whats app